Morning Overview on MSN
RNA-based therapy reaches proof-of-concept for autism-related gene mutations in preclinical models
A single injection into the bloodstream of a mouse corrected a mutation linked to autism in neurons throughout the brain and ...
AIRNA, a biotech company pioneering RNA-editing therapeutics to transform the lives of patients with rare and common ...
ProQR scientists report for the first time in the ADAR RNA editing field in vivo proof of target engagement (RNA editing) leading to meaningful changes in biomarkers in NHPs using Axiomer™ RNA Editing ...
Mammalian immunity has long been thought to rely solely on proteins and specialized immune cells. However, a newly proposed concept—RNA immunity—is reshaping this perspective. In a recent publication ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results